Login / Signup

Combination of anti-PD-L1 antibody with peptide MEL-dKLA targeting M2 tumor-associated macrophages suppresses breast cancer metastasis.

Chanju LeeHyunji LeeHayoon ChoSoyoung KimIlseob ChoiYoung-Sik HwangHyunju JeongHogi JangSehyun PakDeok-Sang HwangIk-Hwan HanHyunsu Bae
Published in: Cancer communications (London, England) (2022)
Keyphrases
  • signaling pathway
  • cancer therapy
  • drug delivery
  • young adults
  • breast cancer risk